Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of depression and anxiety on health-related quality of life changes over time within individuals with rheumatoid arthritis or inflammatory bowel disease: A prospective Canadian cohort study.
Psychological resilience as a behavioral proxy for cognitive reserve in multiple sclerosis: A theoretical reappraisal.
Citronellal improves ischemia-induced pathological senescence of hippocampal neurons and cognitive impairment via regulation of the TRPM2/NMDAR pathway.
Absence of significant hematologic abnormalities in breastfed infants of mothers with multiple sclerosis treated with anti-CD20 therapies.
Herpes Zoster Ophthalmicus Complicated by Optic Neuritis: Diagnostic and Therapeutic Challenges.
Long-Term IFN-β Therapy Enhances and Prolongs IFN Responses in Multiple Sclerosis.
Health Literacy and Unmet Needs in Patients With Multiple Sclerosis: A Cross-Sectional Study.
Exploring the Landscape of Complementary and Alternative Medicine (CAM) among Multiple Sclerosis Patients in Riyadh: Types, Patterns, Health Implications, and Social Drivers - A Cross‑Sectional Study.
Pathological extracellular matrix changes in decellularized normal appearing gray matter and subpial multiple sclerosis lesions.
Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from Germany.
Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.
Spinal cord transverse section hinders Wallerian degeneration and neoangiogenesis after peripheral nerve transection: Involvement of Schwann cells' miR-134-5p.
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.
The many faces of the multiple sclerosis population in Canada.
Cell-type-specific Mendelian randomization analysis of brain single-nucleus eQTLs and neuromyelitis optica spectrum disorder risk.
Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.
Vagus Nerve Hypertrophy in Chronic Inflammatory Demyelinating Polyneuropathy Presenting With Vocal Cord Palsy.
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.
Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.
Hematopoietic monoamine oxidase A deficiency exacerbates neuroinflammation and demyelination in female but not male mice with experimental autoimmune encephalomyelitis.
TREM2 in neurodegenerative diseases and acute neurological injuries: mechanisms to targeted therapies.
The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy.
Causal effects of multiple sclerosis therapies in left-truncated registry data.
Glucocorticoid exposure and social support deficits as longitudinal predictors of long-term neuropsychiatric damage in SLE: insights from the LUMINA cohort (LXXXIII).
Pages
« first
‹ previous
…
891
892
893
894
895
896
897
898
899
…
next ›
last »